ENTRESTO® (sacubitril/valsartan) prescribing information (external link)
LEQVIO® (inclisiran) prescribing information (external link)
This page includes promotional content created and funded by Novartis Pharmaceuticals UK Ltd. Novartis products may be mentioned.
Cardio-metabolic
ENTRESTO® (sacubitril/valsartan)
Video
25 mins 25 secs
Chronic HFrEF – burden, symptoms and diagnosis
Video
43 mins 1 sec
Optimising treatment for people with chronic HFrEF
Video
28 mins 47 secs
Managing renal function in people with HFrEF
LEQVIO® (inclisiran)
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
